Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane Plus Carboplatin in Recurrent Platinum-Sensitive Ovarian Cancer
NCT00466986Phase 2Completed
- Sponsor
- Southeastern Gynecologic Oncology
- Start
- Nov 2005
- Primary completion
- Oct 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Southeastern Gynecologic Oncology. Started Nov 2005; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00466986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466986.